Current role
Biotechnology · Healthcare
Board Member
2024-11-01–present
June Almenoff, M.D., Ph.D.
Equibles does not estimate personal net worth.
Get an email with a short summary when Actinium Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ATNM alertsAbout June Almenoff, M.D., Ph.D.
June Almenoff, M.D., Ph.D. is recorded as Board Member at Actinium Pharmaceuticals, Inc. (ATNM) since November 1, 2024. Actinium Pharmaceuticals, Inc. reported in an 8-K filed November 5, 2024 that June Almenoff, M.D., Ph.D. was appointed director, effective November 1, 2024. Actinium Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Actinium Pharmaceuticals, Inc. includes Sandesh Seth (CEO and Board Member), Matt David (CFO), Matt David, M.D. (CFO) and 5 others.
“On November 1, 2024, June Almenoff, M.D., Ph.D., was appointed as a director of Actinium Pharmaceuticals, Inc. (the "Company") and was also appointed to serve as a member of the Nominating and Corporate Governance Committee.”
Affiliation history
-
Current
2024-11-01–present
-
Current
2024-11-01–present
Company network
Leadership on record at Actinium Pharmaceuticals, Inc.
- Sandesh Seth CEO, Board Member
- Matt David CFO
- Matt David, M.D. CFO
- Ajit S. Shetty Board Member
- David Nicholson Board Member
- Jeffrey W. Chell Board Member
- June S. Almenoff Board Member
- Richard I. Steinhart Board Member